Blood Safety Surveillance
Resources for NHSN Users
Facility Enrollment or Component Activation
-
Facility Enrollment or Component Activation [PDF – 3M]
Audience: Facilities interested in participating in the Hemovigilance Module.
- Activating the Biovigilance Component [PDF – 572K]
Training
Introduction to Hemovigilance Module Reporting
Audience: All Beginner and Intermediate users of the Hemovigilance Module.
Description: This training will include a complete introduction to the NHSN Hemovigilance Module reporting requirements, related documents and forms, and the reporting timeline. Continuing education credits (CEU’s) are available for successful completion.
Hemovigilance Module: Introduction to Analysis [PDF – 941K]
Audience: All Hemovigilance Module users.
Description: This training provides a complete overview of the Hemovigilance Module’s analysis feature.
Hemovigilance Module Quick Learn Series (2016)
Audience: All Hemovigilance Module users.
Description: Quick Learns are short narrated videos that describe the Hemovigilance Module reporting forms and some questions.
- Hemovigilance Module Annual Facility Form [Video – 6 min]
- Hemovigilance Module Adverse Reaction Form [Video – 9 min]
- Hemovigilance Module Adverse Reaction Form’s Medical History Section [Video – 8 min]
- Hemovigilance Module Incident Form [Video – 7 min]
- Hemovigilance Module Denominator Form [Video – 5 min]
- Hemovigilance Module Custom Fields Question [Video – 6 min]
Audience: All current and prospective Hemovigilance users.
Description: Complete this form to request a webinar.
Protocol
- NHSN Manual: Biovigilance Component Protocol January 2017 [PDF – 1M] Guidelines and procedures for monitoring hemovigilance.
Table of Contents:
- Section 1. Hemovigilance Module Surveillance Overview
- Section 2. Hemovigilance Module Annual Facility Survey
-
Section 3: Hemovigilance Module Adverse Reactions
-
Adverse Reaction Case Classification Criteria Tables
- Transfusion-associated circulatory overload (TACO)
- Transfusion-related acute lung injury (TRALI)
- Transfusion-associated dyspnea (TAD)
- Allergic reaction
- Hypotensive transfusion reaction
- Febrile non-hemolytic transfusion reaction (FNHTR)
- Acute hemolytic transfusion reaction (AHTR)
- Delayed hemolytic transfusion reaction (DHTR)
- Delayed serologic transfusion reaction (DSTR)
- Transfusion-associated graft vs. host disease (TAGVHD)
- Post transfusion purpura (PTP)
- Transfusion-transmitted infection (TTI)
- Other/Unknown
- Adverse Reaction Glossary
-
Adverse Reaction Case Classification Criteria Tables
- Section 4. Hemovigilance Module Incidents
- Section 5. Hemovigilance Module Denominators
Data Collection Forms
Hemovigilance Module Annual Facility Surveys
Please select the appropriate annual facility survey.
- 57.300 Hemovigilance Module Annual Acute Care Facility Survey January 2017 [PDF – 126K]
- 57.306 Hemovigilance Module Annual Facility Survey Non-Acute Care Facility January 2017 [PDF – 106K]
Hemovigilance Module Monthly Reporting Plan
Hemovigilance Module Monthly Incident Summary
Hemovigilance Module Monthly Reporting Denominators
Hemovigilance Module Adverse Reaction Forms
Please select the appropriate adverse reaction form.
- 57.318 Hemovigilance Module Transfusion-associated circulatory overload (TACO) January 2017 [PDF – 117K]
- 57.317 Hemovigilance Module Transfusion-related acute lung injury (TRALI) January 2017 [PDF – 118K]
- 57.315 Hemovigilance Module Transfusion-associated dyspnea (TAD) January 2017 [PDF – 115K]
- 57.308 Hemovigilance Module Allergic reaction January 2017 [PDF – 104K]
- 57.312 Hemovigilance Module Hypotensive transfusion reaction January 2017 [PDF – 118K]
- 57.311 Hemovigilance Module Febrile non-hemolytic transfusion reaction (FNHTR) January 2017 [PDF – 115K]
- 57.307 Hemovigilance Module Acute hemolytic transfusion reaction (AHTR) January 2017 [PDF – 107K]
- 57.309 Hemovigilance Module Delayed hemolytic transfusion reaction (DHTR) January 2017 [PDF – 115K]
- 57.310 Hemovigilance Module Delayed serologic transfusion reaction (DSTR) January 2017 [PDF – 116K]
- 57.316 Hemovigilance Module Transfusion-associated graft vs. host disease (TAGVHD) January 2017 [PDF – 117K]
- 57.314 Hemovigilance Module Post transfusion purpura (PTP) January 2017 [PDF – 116K]
- 57.313 Hemovigilance Module Transfusion-transmitted infection (TTI) January 2017 [PDF – 119K]
- 57.320 Hemovigilance Module Other January 2017 [PDF – 116K]
- 57.319 Hemovigilance Module Unknown January 2017 [PDF – 114K]
Hemovigilance Module Incident Form
Supporting Material
Quick Reference Guides
- Create a Group [PDF – 323K]
- Maintain a Group [PDF – 205K]
- Biovigilance Component Alerts [PDF – 418K]
- Hemovigilance Module: Customizing Forms [PDF – 524K]
- Location Mapping in NHSN [PDF – 454K]
- Linking Incident Records to Adverse Reaction Records in the Hemovigilance Module [PDF – 384K]
- Reporting Zero Adverse Events [PDF – 270K]
- Joining a Group [PDF – 408K]
- SAMS Registration Steps [PDF – 105K]
Analysis Resources
Electronic Reporting
FAQs
New Users - Start Here
- Step 1: Enroll into NHSN
- Step 2: Set up NHSN
- Step 3: Report
- Page last reviewed: April 5, 2017
- Page last updated: May 4, 2017
- Content source: